Shuttle Pharmaceuticals Holdings (SHPH) Beginning Cash Balance (2022 - 2025)

Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Beginning Cash Balance of $63404.0 in Q2 2025, up 3.03% quarter-over-quarter from $61540.0 in Q1 2025.

Shuttle Pharmaceuticals Holdings (SHPH) Beginning Cash Balance (2022 - 2025) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Beginning Cash Balance history runs 3 years deep, the most recent figure standing at $63404.0 for Q2 2025.

  • In Q2 2025, Beginning Cash Balance changed N/A year-over-year to $63404.0; the TTM figure through Jun 2025 stood at $124944.0 (changed N/A YoY), while the FY2025 annual figure was $190270.0, up 218.55% from the prior year.
  • Beginning Cash Balance was $63404.0 for Q2 2025 at Shuttle Pharmaceuticals Holdings, up from $61540.0 in the prior quarter.
  • In the past five years, Beginning Cash Balance ranged from a high of $546244.0 in Q1 2023 to a low of $822.0 in Q3 2022.
  • Historically, Beginning Cash Balance has averaged $162247.8 across 3 years, with a median of $63404.0 in 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Shuttle Pharmaceuticals Holdings 2.17 Mn 1.11 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 63,404.00
Jun 30, 2025 63,404.00
Mar 31, 2025 61,540.00
Mar 31, 2025 61,540.00
Jun 30, 2023 139,229.00
Jun 30, 2023 139,229.00
Mar 31, 2023 546,244.00
Mar 31, 2023 546,244.00
Sep 30, 2022 822.00
Sep 30, 2022 822.00